Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Molecular Diagnosis & Therapy|November 23, 2019
Mutation Yield of a Custom 212-Gene Next-Generation Sequencing Panel for Solid Tumors: Clinical Experience of the First 260 Cases Tested Using the JAX ActionSeq™ AssayPavalan Selvam, Meng-Chang Hsiao, Gregory Omerza, et al.Experimental and Molecular Pathology|January 7, 2015
Development and validation of the JAX Cancer Treatment Profile™ for detection of clinically actionable mutations in solid tumorsGuruprasad Ananda, Susan Mockus, Micaela Lundquist, et al.Genetics|March 7, 2018
A Bayesian Framework for Generalized Linear Mixed Modeling Identifies New Candidate Loci for Late-Onset Alzheimer's DiseaseXulong Wang, Vivek M Philip, Guruprasad Ananda, et al.BMC Medical Genomics|July 3, 2019
Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelinesXing Yi Woo, Anuj Srivastava, Joel H Graber, et al.Scientific Reports|December 19, 2018
High-resolution deconstruction of evolution induced by chemotherapy treatments in breast cancer xenograftsHyunsoo Kim, Pooja Kumar, Francesca Menghi, et al.G3 (Bethesda, Md.)|April 19, 2019
The Genome of C57BL/6J "Eve", the Mother of the Laboratory Mouse Genome Reference StrainVishal Kumar Sarsani, Narayanan Raghupathy, Ian T Fiddes, et al.Biorxiv : the Preprint Server for Biology|February 27, 2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancerXin Cheng, Changli Qian, Erica Holdridge, et al.Nature Communications|May 4, 2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancerXin Cheng, Yadong Zhang, Changli Qian, et al.Genome Research|March 13, 2013
The origin, evolution, and functional impact of short insertion-deletion variants identified in 179 human genomesStephen B Montgomery, David L Goode, Erika Kvikstad, et al.Nature Communications|September 24, 2022
Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitorsYoshihisa Kobayashi, Geoffrey R Oxnard, Elizabeth F Cohen, et al.Pageof 4